News & Updates
Filter by Specialty:
Anti-HER-2/neu vaccine may benefit gastric cancer patients
In patients with HER-2-overexpressing metastatic or advanced gastric/gastroesophageal (G/GEJ) adenocarcinoma, a regimen comprising standard-of-care chemotherapy and a HER2-targeting peptide vaccine induced antibody responses that corresponded with tumour size reduction, according to an analysis of the HERIZON study which looked into the correlation between antibody responses and clinical outcomes.
Anti-HER-2/neu vaccine may benefit gastric cancer patients
06 Sep 2023Nutrition literacy not enough to cause basic dietary changes in NAFLD
Patients with nonalcoholic fatty liver disease (NAFLD) continue to follow a poor dietary pattern despite receiving medical recommendations to lose weight and having nutritional literacy and perception that are similar to those without NAFLD, reports a study.
Nutrition literacy not enough to cause basic dietary changes in NAFLD
03 Sep 2023Do weak opioids increase risk of GI cancers?
Evidence on the association of weak opioids with a higher risk of oesophageal and colorectal cancer is not reliable, but there appears to be a small association with gastric cancer, suggests a study.
Do weak opioids increase risk of GI cancers?
30 Aug 2023Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
A dexamethasone-free regimen helps improve control of nausea and vomiting in patients receiving “highly emetogenic” chemotherapy, with the antiemetic effect being superior to that of a dexamethasone-based regimen, according to the results of a phase III trial presented at ASCO Breakthrough 2023.
Chemo-induced nausea, vomiting? There’s a dexamethasone-free regimen for that
28 Aug 2023Functional anorectal pain ups incidence of ED, depression, anxiety in men
Men with functional anorectal pain (FARP) are more vulnerable to erectile dysfunction (ED), depression, and anxiety, a study has shown. Moreover, the incidence of these conditions increases with pain severity.